“Chimeric Antigen Receptor T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: A Canadian Perspective”. 2022. Canadian Hematology Today 1 (2): 26–33. https://doi.org/10.58931/cht.2022.1214.